Editorial p625 Accelerating the path towards a cure for Parkinson's disease The Lancet Neurology +...

https://www.thelancet.com/journals/laneur/issue/vol24no8/PIIS1474-4422(25)X0008-9 Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study Amit Bar-OrMichal DufekHrvoje BudincevicJelena DrulovicMario HabekLe H Huaand others The Lancet NeurologyVol. 24No. 8p656–666 https://www.thelancet.com/collections/neurology?dgcid=hubspot_email_infocusalerts-neurology_feature&parent=001585&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-9HtE8sxUgnm93GBIByy7KsqTc8yPeSLgZuyTXRoJEJI4h6BVDldWMh6DMp_jwbZc0xFRPiAjWQ92t6kZwLNN3h1rxG5g&_hsmi=373022104&utm_content=372951459&utm_source=hs_email Published: August, 2025